Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

971639

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timeframe is to resolve the national shortage of EpiPen 0.3mg Auto-Injectors.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	173542
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>Departmental officials are in regular contact with Mylan, the United Kingdom licensed supplier of Epipens, as there have been ongoing supply issues affecting this product. Supplies are currently available of the 0.3mg, although limited, and are being closely managed to ensure that pharmacies can obtain stock to fulfil prescription for patients. Mylan anticipates that supplies will stabilize in the fourth quarter of 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2018 17:02:17 answering member 4067 label Biography information for Steve Brine
tabling member	1513 label Biography information for Jo Swinson

971667

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Data Protection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will clarify whether (a) pursuant to the Answer of 6 September 2018 to Question 168973, GP practices will not be allowed to charge third parties for subject access to patient medical records or (b) pursuant to the Answer of 12 July 2018 to Question 162134, the right of access under GDPR confers more personal information than is needed or is justified for insurance underwriting. Accordingly, insurance companies should instead use the established mechanism of the Access to Medical Reports Act 1988 (AMRA) to obtain summary medical reports from general practitioners (GPs).
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	173507
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>According to the General Data Protection Regulation (GDPR), general practitioners (GPs) cannot charge patients or third parties for subject access to patient medical records, except where the request is manifestly unfounded or excessive and where the third party is an insurance company. Where the access request is deemed manifestly unfounded or excessive, the GP can either refuse the request or charge an appropriate administration charge for the work involved. Also, where the third party is an insurance company, the Access to Medical Reports Act (AMRA) 1988 would apply. The AMRA allows the GP to charge a reasonable fee to cover the cost of copying the report.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2018 16:56:41 answering member 4067 label Biography information for Steve Brine
tabling member	298 label Biography information for Steve McCabe

971708

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of the WHO Framework Convention on Tobacco Control’s proposal for a worldwide ban on advertising, promoting and sponsoring e-cigarettes on the Government’s tobacco control plan; and if he will make a statement.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	173548
answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.</p><p> </p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173549 173550 question first answered 17/09/2018 14:00:27 answering member 4067 label Biography information for Steve Brine
tabling member	1565 label Biography information for Sir Philip Davies

971709

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	WHO Framework Convention on Tobacco Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on his Department's participation in the 8th Conference of the Parties to the World Health Organisation Framework Convention on Tobacco Control in October 2018.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	173549
answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.</p><p> </p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173548 173550 question first answered 17/09/2018 14:00:27 answering member 4067 label Biography information for Steve Brine
tabling member	1565 label Biography information for Sir Philip Davies

971710

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	WHO Framework Convention on Tobacco Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department's priorities are for the Eighth session of the Conference of the Parties to the World Health Organisation Framework Convention on Tobacco Control to be held in October 2018.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	173550
answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.</p><p> </p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173548 173549 question first answered 17/09/2018 14:00:27 answering member 4067 label Biography information for Steve Brine
tabling member	1565 label Biography information for Sir Philip Davies

971761

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the money that would be accrued to the public purse of the introduction of charges by NICE for companies whose products are selected for technology appraisal.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	173639
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>The Department published a consultation on 10 August titled ‘NICE's technology appraisal and highly specialised technology work programmes – Charging and Appeal Panels’ which ran until 14 September 2018.</p><p> </p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels" target="_blank">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels</a></p><p> </p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.</p><p> </p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173640 173641 question first answered 09/10/2018 17:00:54 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

971762

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse in foregone (a) tax and (b) other revenues in the event that NICE introduces charges for technology appraisals and companies choose not to launch products in England.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	173640
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>The Department published a consultation on 10 August titled ‘NICE's technology appraisal and highly specialised technology work programmes – Charging and Appeal Panels’ which ran until 14 September 2018.</p><p> </p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels" target="_blank">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels</a></p><p> </p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.</p><p> </p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173639 173641 question first answered 09/10/2018 17:00:54 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

971763

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential effectiveness of options available to NICE other than charging for technology appraisals to tackle changes in the level of its central Government funding; and if he will make a statement.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	173641
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>The Department published a consultation on 10 August titled ‘NICE's technology appraisal and highly specialised technology work programmes – Charging and Appeal Panels’ which ran until 14 September 2018.</p><p> </p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels" target="_blank">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels</a></p><p> </p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.</p><p> </p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173639 173640 question first answered 09/10/2018 17:00:54 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

971811

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what facilities in the UK offer high-energy proton beam cancer therapy treatment in (a) the NHS and (b) the private sector.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	173485
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>In April 2012, the Secretary of State for Health and Social Care announced that £250 million would be invested to build proton beam therapy facilities at The Christie Hospital in Manchester and University College London Hospital (UCLH). Contracts were signed with Varian Medical Systems, Interserve Construction at The Christie, and Bouygues UK at UCLH at the end of July 2015. The Christie has been operational since 20 August 2018 and expects the first patients to be treated in the autumn. UCLH is currently on schedule to begin treating patients in summer 2020.</p><p> </p><p>NHS England does not hold information about high-energy proton beam provision in the private sector.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2018 16:53:23 answering member 4067 label Biography information for Steve Brine
tabling member	114 label Biography information for Tim Loughton

971813

registered interest
date	11/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS England patients have been treated with high-energy proton beam cancer therapy in England and Wales in each of the last five years.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	173486
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>NHS England has not funded any patients to have high-energy proton beam therapy in England and Wales in the last five years.</p><p> </p><p>Over the past five years, 895 National Health Service patients have been treated overseas with high-energy proton beam therapy at a total cost of just over £91 million. These figures include patients from England, Scotland and Northern Ireland but exclude patients from Wales. NHS England does not routinely split financial information between treatment and travel/subsistence costs. Further detail is provided in the following table.</p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>Total</p></td></tr><tr><td><p>Number of patients approved for referral</p></td><td><p>119</p></td><td><p>144</p></td><td><p>213</p></td><td><p>203</p></td><td><p>216</p></td><td><p>895</p></td></tr><tr><td><p>Total cost</p></td><td><p>£9.13 million</p></td><td><p>£12.63 million</p></td><td><p>£20.81 million</p></td><td><p>£24.51 million</p></td><td><p>£24.19 million</p></td><td><p>£91.27 million</p></td></tr></tbody></table><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 173487 question first answered 09/10/2018 16:56:45 answering member 4067 label Biography information for Steve Brine
tabling member	114 label Biography information for Tim Loughton